Start with governance
Frame, scope, and sequence AI for life sciences before a single use case ships.
Resources
The life sciences AI knowledge base.
400+ white papers, webinars, blogs, and case studies from the team that has governed AI, validated platforms, and modernized compliance for 900+ regulated organizations.
30
White Papers and Guides
52
Webinars
238
Blogs
80
Case studies
Resources sections
Thought Leadership from Trusted Experts
Thoughts, perspectives, and guidance on the on the challenges and solutions captivating the life sciences industry today.
Blogs
Practical perspectives from the teams building in regulated environments every day.
Open BlogsCase Studies
Real-world proof from work where speed, governance, and compliance had to hold together.
Open Case StudiesNews & Events
Updates, events, and conversations that show how the market is moving.
Open News & EventsWhite Papers
Deep guidance shaped by 25 years of expertise to help you move with confidence.
Open White PapersWebinars
Live and on-demand sessions that turn hard questions into practical next steps.
Open WebinarsVideos
Short explainers and recorded insights for a faster path to the good stuff.
Open VideosStart here — by decision
Where are you in the regulated AI journey?
Four sequences, mapped to the decisions life sciences leaders actually face. Each one starts with a primary read and a quick follow-on.
Modernize validation
Move from CSV to CSA, automate testing, and keep cloud platforms continuously validated.
Operate Veeva for AI
Get more value from your Vault investment and prepare the operating model for agent-led work.
Defend against third-party risk
Modernize TPRM for an AI-driven supply chain and prepare for the next clinical-vendor incident.
Featured white papers and guides
Four reads that ground a governed AI program.
Guide
AI Governance for Life Sciences: The Enterprise Framework
Lifecycle controls, vendor AI risk, citizen development, and responsible adoption — the framework leadership teams use to scale AI without rework.
Read the guide Guide47 AI Use Cases for Quality, Regulatory, Clinical, and Manufacturing
The use-case dossier teams reach for when prioritizing where AI actually pays back in regulated work.
Read the guide GuideAI Readiness Assessment for Life Sciences
A practical assessment to find where AI is ready to deploy, where it is not, and what to fix first.
Read the guide GuideAI-Ready Veeva Vault Operating Model
How to evolve the Vault operating model so AI agents can act on content without breaking governance.
Read the guideFeatured proof
Outcome-led case studies.
Real engagements with measurable results — validation cycles cut, AI delivered with governance, audits cleared on schedule.
AI deploymentGovernance
Driving Quality Excellence and Operational Efficiency for a Global CDMO
Global contract development and manufacturing organization (CDMO) scaling quality operations across four U.S. sites with an EU and Asia roadmap.
How a global CDMO built an AI-enabled digital quality model across deviation investigation, quality KPI visibility, and SOP interpretation to improve productivity, regulatory confidence, and global quality execution.
Deviation cycle time
~40% reduction
AI deploymentGovernance
Qualifying Cybersecurity Controls for Regulated Operations
Global biopharmaceutical company operating regulated technology, cybersecurity, and quality systems at enterprise scale.
How a global biopharmaceutical company advanced CyberArk qualification by aligning requirements, risk, configuration, access, testing, and controlled validation evidence.
Qualification path
Controlled evidence chain
AI deploymentGovernance
Scaling eTMF Completeness for a Hyper-Growth Biotech
Hyper-growth biotech scaling vaccine clinical-trial operations across multiple Contract Research Organizations (CROs).
How a hyper-growth biotech replaced disconnected eTMF spreadsheets with Veeva Vault workflows for real-time TMF completeness, CRO accountability, and inspection-ready oversight.
Fragmentation removed
3 logs to 1 system
AI deploymentGovernance
Transforming Third-Party Vendor Risk Management at Enterprise Scale
Global biopharmaceutical company focused on severe autoimmune diseases and cancer, operating in more than 30 countries with a third-party ecosystem of 150+ critical vendors spanning manufacturing, CROs, IT service providers, and logistics partners.
Discover how global biopharma transformed third-party risk management (TPRM) with USDM's continuous monitoring, cutting assessment times by 60%.
Assessment speed
60% reduction